Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
2.00 |
12/21/2023 - 12:00am to 12/21/2024 - 12:00am |
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
Advances in Hepatocellular and Biliary Tract Cancers Impacting Patient Outcomes |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future |
1.75 |
07/21/2023 - 12:00am to 07/21/2024 - 12:00am |
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors |
1.75 |
08/09/2023 - 12:00am to 08/09/2024 - 12:00am |
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates |
1.25 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
Locoregional Management of Breast Cancer with SABCS Updates |
1.25 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
Advances in the Management of Metastatic Castration-Resistant Prostate Cancer: Expert Guidance and Resources for the Interdisciplinary Team |
1.25 |
12/21/2023 - 12:00am to 12/21/2024 - 12:00am |
What Drives Reimbursement for Biomarker Testing? |
1.25 |
06/15/2023 - 12:00am to 06/15/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix |
1.00 |
12/05/2023 - 12:00am to 12/05/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Early-Stage Non-Small Cell Lung Cancer |
1.00 |
02/27/2024 - 12:00am to 02/27/2025 - 12:00am |
NCCN Guidelines® Insights - Biliary Tract Cancers, Version 2.2023 |
1.00 |
07/10/2023 - 12:00am to 07/10/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Relapsed/Refractory Mantle Cell Lymphoma |
1.00 |
04/26/2023 - 12:00am to 04/26/2024 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma |
1.00 |
06/30/2023 - 12:00am to 06/28/2024 - 12:00am |
Navigating Change: Best Practices for Integrating WHO/ICC Classification Systems in the Management of Hematologic Malignancies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |